The “Cloud-based Solutions for Drug Discovery, Development and Manufacturing Market by Type of Cloud (Private, Public and Hybrid)”

 

To order this 225+ page report, please visit this link

 

Key Inclusions

§  A detailed review of the current market landscape of companies offering cloud-based services, platforms, and tools for drug discovery, development and manufacturing, providing information on year of establishment, company size (in terms of number of employees), company type, location of headquarters, quality certifications, type of cloud (public, private, hybrid), type of service (IaaS, PaaS, SaaS), area of application (drug discovery, drug development, drug manufacturing), additional capabilities, and additional services offered.

§  An in-depth analysis of the contemporary trends, highlighted through various schematic representations, such as 4D bubble analysis based on type of service, area of application, company size and quality certifications, grid representation based on type of service, area of application, and type of cloud, a waffle chart based on geography and COVID-19-related initiatives, a mekko chart based on geography and additional capabilities and a world map highlighting the location of service providers.

§  An insightful competitiveness analysis of the cloud-based solution providers, taking into consideration their supplier strength (in terms of experience of the service provider), and popularity index (in terms of type of cloud, type of service, area of application, additional capabilities, additional services offered, COVID-19-related initiatives, number of quality certifications, number of partnerships, number of followers on twitter, and Google hits).

§  Elaborate profiles of key players that provide cloud-based solutions for drug discovery, development and manufacturing. Each company profile features a brief overview of the company (including information on year of establishment, number of employees, location of headquarters and key members of the executive team), recent developments and an informed future outlook.

§  An analysis of the partnerships that have been inked by stakeholders in this domain, in the period between 2015 and 2020, covering clinical data management agreements, platform development / improvement agreements, research agreements, research and platform development agreements, regulatory process management agreements, technology / data integration agreements, and other relevant types of deals. 

§  An insightful analysis highlighting the likely cost saving potential associated with the use of cloud-based solutions for drug discovery, development and manufacturing, taking into consideration various parameters, such as pharmaceutical R&D expenditure, drug discovery expenditure / budget, clinical trials expenditure, drug manufacturing expenditure and increase in efficiency by adoption of cloud-based solutions.

§  An in-depth analysis of the opportunities and the overall cost savings associated with integration of key tools and technologies, such as artificial intelligence, deep learning, machine learning, and quantum computing with cloud-based solutions for pharmaceutical product development and manufacturing. Further, it provides a detailed analysis on ease of implementation and associated risk in integrating above-mentioned technologies, based on the trends highlighted in published literature and patents.

 

The report also features the likely distribution of the current and forecasted opportunity across important market segments, mentioned below:

§  Type of Cloud

§  Private

§  Public

§  Hybrid

 

§  Type of Cloud Service

§  IaaS

§  PaaS

§  SaaS

 

§  Area of Application

§  Drug Discovery

§  Drug Development

§  Drug Manufacturing

 

§  End-User

§  Biotech Vendor

§  Contract Research Organizations

§  Pharmaceutical Companies

§  Others

 

§  Key Geographical Regions

§  North America

§  Europe

§  Asia-Pacific

§  Middle East and North Africa

§  Latin America

§  Rest of the World 

 

The report includes detailed transcripts of discussions held with the following experts:

§  Velizar Natovski (Regional Manager North and South America, CloudSigma)

§  Paolo Colombo (Vice President Growth, InSilicoTrials)

 

To request sample pages, please visit this link

 

Key Questions Answered

§  Who are the leading players offering cloud-based solutions for drug discovery, development and manufacturing?

§  What kind of cloud services are commonly offered by companies in this domain?

§  What kind of partnership models are commonly adopted by stakeholders in this industry?

§  What is the likely cost saving potential associated with the use of cloud-based solutions in drug discovery, development and manufacturing processes?

§  How is the current and future opportunity likely to be distributed across key market segments?

§  What kind of performance enhancements are possible by integrating artificial intelligence, deep learning, machine learning and quantum computing, with existing cloud-based solutions?

§  What is the impact of the COVID-19 pandemic within this market?

 

You may also be interested in the following titles:

1.       Digital Solutions for Biomarkers Market, 2021-2030

2.     AI-based Drug Discovery Market: Focus on Deep Learning and Machine Learning, 2020-2030

3.       In Silico / Computer-Aided Drug Discovery Services Market, 2020-2030

 

Contact Us

Gaurav Chaudhary

+1 (415) 800 3415

gaurav.chaudhary@rootsanalysis.com